About Campbell Murray
Campbell Murray is a director at Lighthouse Pharmaceuticals.
Experience
This experience comes from Campbell Murray's profile and from SEC filings. For roles taken from filings, the years are when the filings name Campbell Murray in the role, so the role may have started earlier or lasted longer.
Lighthouse Pharmaceuticals, Inc. Current
Director
2026 – Present · Novato, CA
Develops experimental medicines for people with neurodegenerative and inflammatory diseases.
SY
Synchron Current
Director
2025 – Present
LP
Lumos Pharma Current
Exec. Chair of the Board
2024 – Present
UB
Umoja Biopharma Current
Director
2024 – Present
IA
ImmunOs Therapeutics AG Current
Board Observer
2024 – Present
GB
GEMMA Biotherapeutics Current
Director
2024 – Present
CE
Cerevance Current
Director
2024 – Present
DV
Double Point Ventures Current
Co-founder & Managing Partner
2022 – Present
BV
Bioluminescence Ventures
Senior Partner
2024 – 2025
CB
Carbon Biosciences
Director
2023 – 2024
AC
Agent Capital
General Partner
2023 – 2024
DF
Diabetes Free
President & Chief Operating Officer
2020 – 2022
IB
Intima Bioscience
President & Chief Operating Officer
2020 – 2022
TI
TigaTx
Director
2020
RI
Renovacor, Inc.
Director
2019 – 2020
TT
TScan Therapeutics
Director
2018 – 2020
ET
Expansion Therapeutics
Director
2018 – 2020
LH
Lemonaid Health
Director
2017 – 2020
AN
Annexon
Director
2014 – 2020
NF
Novartis Venture Fund
Managing Director
2006 – 2020
Key Colleagues at Startups
The people Campbell Murray works with at each company, as listed on that company's latest Form D.
Lighthouse Pharmaceuticals, Inc. · Form D, May 7, 2026
SD
Stephen Dominy
Director
CL
Casey Lynch
Chief Executive Officer and director